| Ytd | 17.97% | |
| 1y | 10.92% |
| Open | 48.13 | Prev Close | 47.96 | Low | 47.97 | High | 50.05 | Mkt Cap | 1.67B |
| Vol | 120.87K | Avg Vol | 68.04K | EPS | 5.04 | P/E | 9.80 | Forward P/E | 19.67 |
| Beta | 1.11 | Short Ratio | 4.05 | Inst. Own | 52.16% | Dividend | 3.12 | Div Yield | 6.51 |
| Ex Div Date | 08-10 | Earning | 11-06 | 50-d Avg | 49.86 | 200-d Avg | 47.52 | 1yr Est | 45.00 |
Rapid weight loss can lead to issues with bone quality, particularly in older adults.
Milestone advances the technology behind Hydreight's strategic investment and previously announced U
Milestone advances portfolio company's intellectual-property foundation for InsuTab™ and BuccaGLP™,
Western Midstream, Global Partners and NGL Energy Partners have been highlighted in this Industry Ou
Following a careful analysis of the Zacks Oil and Gas - Refining & Marketing MLP industry, we advise
Eli Lilly is building a dominant obesity and diabetes treatment portfolio, positioning itself as a h
New approach proposes an alternative to repeated injections HOUSTON, Oct. 7, 2026 /PRNewswire/ -- Fi
Novo Nordisk rose dramatically because investors were excited after it launched the first GLP-1 weig
Oral GLP-1 market projected to expand from $5.1 billion in 2026 to $89 billion in 2034 Novo announc
EQT (NYSE: EQT - Get Free Report) and Global Partners (NYSE: GLP - Get Free Report) are both energy
MichaelAaron Flicker, founder and CEO of XenoPsi Ventures, walks through the impact that GLP-1 drugs
Bank of America Corp DE acquired a new position in shares of Global Partners LP (NYSE: GLP) in the s
Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in
In a predefined MRI substudy, trevogrumab prevented 70% of muscle loss associated with semaglutide t
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
In post-hoc analyses of ATTAIN-1, Foundayo 17.2 mg was associated with a predicted 57% and 18% reduc
In ACHIEVE-4, participants taking Foundayo experienced a 16% lower risk of MACE-4 and a 23% lower ri
Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) says new analysis of its ketamine-based alcohol trea
Eli Lilly's high valuation could limit the stock's future returns. Viking Therapeutics is a much sma
Novo this week laid out an ambitious strategy to reignite growth beyond its top-selling Wegovy and O
Global Partners (NYSE:GLP) reported quarterly earnings of $1.86 per share which beat the analyst con
Global Partners (NYSE:GLP) reported quarterly earnings of $1.85 per share which beat the analyst con
Stifel analyst Selman Akyol maintains Global Partners (NYSE:GLP) with a Hold and raises the price
Market sentiment declines, Nasdaq falls 1%. Nvidia down 5%, Salesforce up 4% in earnings. Initial jo
U.S. stock futures lower, Carter's and Dell report earnings, Global Partners and Block announce
Stifel analyst Selman Akyol maintains Global Partners (NYSE:GLP) with a Hold and lowers the price
Global Partners (NYSE:GLP) reported quarterly earnings of $0.66 per share which missed the analyst c
Global Partners (NYSE:GLP) reported quarterly earnings of $0.55 per share which missed the analyst c
U.S. stocks rallied Thursday after the Trump administration signed its first major trade agreement w
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first
Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly e
Companies Reporting Before The Bell • Sprott (NYSE:SII) is likely to report quarterly earnings at $
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to repo
Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEPC) is projected to report ea
During Wednesday's morning trading, 251 companies set new 52-week highs.
Tuesday morning saw 244 companies set new 52-week highs.
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday.
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321.